Literature DB >> 3241216

5HT3 receptor-mediated vasodilation in the human forearm.

G J Blauw1, P van Brummelen, P C Chang, P Vermeij, P A van Zwieten.   

Abstract

The role of neuronal 5HT3 receptors in the vascular response induced by serotonin (5-hydroxytryptamine, 5HT) was investigated in seven healthy volunteers (aged 22-32 years). Single infusions of 5HT (1 ng/kg per min) and acetylcholine (500 ng/kg per min) were administered into the brachial artery in random order. Subsequently, 5HT and acetylcholine were administered together with the selective 5HT3 antagonist ICS 205-930 (700 ng/kg per min). After a pause of at least 1 h the single infusions of 5HT and acetylcholine were repeated. Finally, 5HT and acetylcholine were infused together with atropine (100 ng/kg per min). Forearm blood flow was measured by venous occlusion plethysmography. The heart rate and intra-arterial blood pressure were recorded semi-continuously. 5HT induced an initial transient increase in forearm blood flow (316 +/- 55%, mean +/- s.e.m., P less than 0.05), followed by persistent increase (90 +/- 22%, P less than 0.05). Acetylcholine elicited a monophasic vasodilation (delta forearm blood flow 475 +/- 123%, P less than 0.05). ICS 205-930 attenuated both the initial transient vasodilation and the persistent dilatory response to 5HT (P less than 0.05 for both), but did not significantly influence the vascular response to acetylcholine. Atropine abolished the dilator response to acetylcholine (P less than 0.05), but did not influence the biphasic vasodilation induced by 5HT. These results show that the biphasic vasodilation induced by 5HT was antagonized by ICS 205-930, indicating that this response was mediated by neuronal 5HT3-receptor activation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3241216     DOI: 10.1097/00004872-198812040-00006

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Arterial dilatation and venous constriction induced by serotonin in the elderly.

Authors:  G J Blauw; P van Brummelen; P C Chang; P Vermeij; P A van Zwieten
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 2.  The role of serotonin in cardiovascular diseases and their treatment.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

3.  Digital blood flow and 5-hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.

Authors:  B Marasini; C Bassani
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.